Cite
Eslamizar L, Petrovas C, Leggat DJ, et al. Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center. NPJ Vaccines. 2021;6(1):15doi: 10.1038/s41541-020-00277-1.
Eslamizar, L., Petrovas, C., Leggat, D. J., Furr, K., Lifton, M. L., Levine, G., Ma, S., Fletez-Brant, C., Hoyland, W., Prabhakaran, M., Narpala, S., Boswell, K., Yamamoto, T., Liao, H. X., Pickup, D., Ramsburg, E., Sutherland, L., McDermott, A., Roederer, M., Montefiori, D., Koup, R. A., Haynes, B. F., Letvin, N. L., & Santra, S. (2021). Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center. NPJ vaccines, 6(1), 15. https://doi.org/10.1038/s41541-020-00277-1
Eslamizar, Leila, et al. "Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center." NPJ vaccines vol. 6,1 (2021): 15. doi: https://doi.org/10.1038/s41541-020-00277-1
Eslamizar L, Petrovas C, Leggat DJ, Furr K, Lifton ML, Levine G, Ma S, Fletez-Brant C, Hoyland W, Prabhakaran M, Narpala S, Boswell K, Yamamoto T, Liao HX, Pickup D, Ramsburg E, Sutherland L, McDermott A, Roederer M, Montefiori D, Koup RA, Haynes BF, Letvin NL, Santra S. Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center. NPJ Vaccines. 2021 Jan 25;6(1):15. doi: 10.1038/s41541-020-00277-1. PMID: 33495459; PMCID: PMC7835239.
Copy
Download .nbib